UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 4, 2020
Accession Number:
Submission Type:
CIK: 0001498382
Company Name: Kintara Therapeutics, Inc.
File Number: 333-249675